The company’s net profit fell to INR 133 million for the quarter ended March 31, down from INR 335.1 million in the same period last year.
Venky’s poultry and poultry products business — which contributes approximately 54% of its total revenue — saw a staggering 89?cline in profit before tax and interest. This segment includes the production and sale of day-old broiler and layer birds.
In contrast, the company’s animal health products segment grew 5% year-on-year, while profits from the oilseed segment more than doubled. Venky’s processes oilseeds like soy to produce edible oil, and sells or repurposes the de-oiled cake as poultry feed — supporting its vertically integrated operations.
Total revenue from operations declined by 5.9% to INR 8.43 billion in Q4.
Despite the setback in poultry margins, Venky’s is diversifying. The company announced its entry into the ready-to-cook spices segment with a range of ready-mix powders. Commercial production is expected to begin by the end of Q1 FY26, with a project cost of INR 160 million, fully funded through internal accruals.
Additionally, the firm will invest INR 700 million to expand its Specific Pathogen Free (SPF) egg production unit, a key supply element for vaccine manufacturers.
Following the earnings report, Venky’s stock dipped 0.5%.
